ArticleClinical ophthalmology (Auckland, N.Z.)2024
Visual Outcomes and Patient Satisfaction with a Hydrophobic Acrylic Monofocal IOL Delivered Using a Manual System.
Article in Clinical ophthalmology (Auckland, N.Z.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Intermediate Visual Performance of Clareon Versus Eyhance Enhanced Monofocal Intraocular Lenses.Diagnostics (Basel, Switzerland) · 2026Article
- Prospective Randomized Study of Visual Outcomes with Mini-Monovision Between the Light-Adjustable Lens and Clareon Monofocal Toric Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate visual outcomes and patient satisfaction at far and intermediate distances, up to 3 months postoperatively, in patients implanted with a hydrophobic acrylic intraocular lens (IOL) using a manual delivery system. Methods: This was a prospective single-arm study of visual outcomes and patient satisfaction after successful bilateral cataract surgery with the Clareon monofocal and monofocal toric IOL using the Monarch IV delivery system. Endpoints included bilateral visual acuity, manifest refraction, and satisfaction assessed at 1 and 3 months post-operatively, as well as a surgeon survey of in-the-bag placement and satisfaction. Results: A total of 28 patients (56 eyes) completed the study. At 3 months postoperatively, mean uncorrected and corrected binocular visual acuities at distance were 0.03 ± 0.04 logMAR and 0.00 ± 0.02 logMAR, respectively. For intermediate vision (66cm), 98% of eyes (55/56) had corrected monocular visual acuity 20/25 or better. In addition, mean uncorrected and corrected binocular visual acuities at intermediate (66cm) were 0.09 ± 0.05 logMAR and 0.04 ± 0.05 logMAR, respectively. Patient reported satisfaction with their vision was 88% (25/28). The IOL was delivered smoothly into the capsular bag in 89% (50/56) of eyes. Conclusion: Clareon monofocal and monofocal toric IOL delivered with Monarch IV can provide excellent distance vision and intermediate vision, good spectacle independence, high reported patient satisfaction, consistent in-the-bag delivery, and high surgeon satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.